Back to search
Scientific Name: Cryptenamine
Brand Name: Not Available
Company Owner: Medpointe pharmaceuticals medpointe healthcare inc
Mechanism Of Action Cryptenamine has a marked and re-producible depressor effect when given intravenously to hypertensive patients, however the mechanism of action is not known. Some evidence has suggested that cryptenamine acts in a similar fashion to atropine, which lowers the “rest and digest” activity of all muscles and glands regulated by the parasympathetic nervous system. This occurs because atropine is a competitive inhibitor of the muscarinic acetylcholine receptors (acetylcholine is the neurotransmitter used by the parasympathetic nervous system) . Therefore muscarinic acetylcholine receptors will be listed as experimental targets for cryptenamine.
Description of the Drug: Not Available
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from